Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of dapagliflozin on cardiac function following anterior myocardial infarction in non-diabetic patients – DACAMI (a randomized controlled clinical trial)
Khairy Abdel Dayem, Omar Younis, Bassem Zarif, et al.
International Journal of Cardiology (2023) Vol. 379, pp. 9-14
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

SGLT2 inhibitors: Beyond glycemic control
Irtiza Hasan, Tasnuva Rashid, Vishal Jaikaransingh, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 35, pp. 100335-100335
Open Access | Times Cited: 16
Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: A meta-analysis of randomized controlled trials
Renzo Laborante, Donato Antonio Paglianiti, Emiliano Bianchini, et al.
European Journal of Internal Medicine (2025)
Open Access | Times Cited: 1
The effect of sodium-glucose co-transporter 2 inhibitors on clinical outcomes after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
Ubaid Khan, Ahmed Mazen Amin, Amira Mohamed Taha, et al.
Future Cardiology (2025), pp. 1-14
Open Access | Times Cited: 1
Impact of sodium‒glucose cotransporter‐2 inhibitors in patients with recent versus previous myocardial infarction: a systematic review and meta-analysis
Pedro Gabriel Scardini, Eric Katsuyama, A Prata, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS‐MI): rationale and design
Jaclyn Carberry, Mark C. Petrie, Matthew M.Y. Lee, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 4, pp. 2001-2012
Open Access | Times Cited: 7
Dapagliflozin Effects on Cardiac Deformation in Heart Failure and Secondary Clinical Outcome
Maria Concetta Pastore, A. Stefanini, Giulia Elena Mandoli, et al.
JACC. Cardiovascular imaging (2024)
Open Access | Times Cited: 6
Efficacy of Sodium‐Glucose Cotransporter‐2 Inhibitors in Patients With Acute Myocardial Infarction: A Meta‐Analysis of Randomised Controlled Trials
Mushood Ahmed, Hritvik Jain, Hira Javaid, et al.
Endocrinology Diabetes & Metabolism (2024) Vol. 7, Iss. 5
Open Access | Times Cited: 5
Safety and efficacy of early initiation of sodium-glucose cotransporter-2 inhibitors after an acute coronary syndrome event: a meta-analysis of randomized controlled trials
Renzo Laborante, Gianluigi Savarese, Giuseppe Patti, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 7, pp. 646-648
Closed Access | Times Cited: 4
Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
Michele Maremmani, Ramin Ebrahimi, Marco Centola, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction
Nicia I. Profili, Roberto Castelli, Roberto Manetti, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 720-720
Open Access
Emerging horizons: clinical applications and multifaceted benefits of SGLT-2 inhibitors beyond diabetes
Qing Feng, Moya Wu, Zizhao Mai
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
SGLT2 Inhibitors’ Cardiovascular Benefits in Individuals Without Diabetes, Heart Failure, and/or Chronic Kidney Disease: A Systematic Review
Sajad Khiali, Mohammadreza Taban Sadeghi, Parvin Sarbakhsh, et al.
The Journal of Clinical Pharmacology (2023) Vol. 63, Iss. 12, pp. 1307-1323
Closed Access | Times Cited: 10
Effectiveness of sodium–glucose cotransporter-2 inhibitors in patients with acute myocardial infarction with or without type 2 diabetes: a systematic review and meta-analysis
Bin Zhang, Sun Gang, Zhiquan Li, et al.
Journal of Cardiovascular Pharmacology (2024) Vol. 84, Iss. 1, pp. 18-25
Closed Access | Times Cited: 2
Protective Mechanisms of SGLTi in Ischemic Heart Disease
Lei Liao, Tong Wang, Lu Zhang, et al.
Journal of Cardiovascular Translational Research (2024) Vol. 17, Iss. 5, pp. 1018-1035
Closed Access | Times Cited: 2
Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Acute Coronary Syndrome
Jiawei Song, Yan Liu, Yani Xu, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 6, pp. 1847-1855
Open Access | Times Cited: 1
Effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) on N-terminal pro-B-type natriuretic peptide (NT-proBNP) level and structural changes following myocardial infarction: A systematic review and meta-analysis
Sereen Banjar, Sarah Alharbi, Ibrahim Omer, et al.
International Journal of Cardiology (2024) Vol. 410, pp. 132239-132239
Closed Access | Times Cited: 1
Effect of sodium glucose cotransporter 2 inhibitors on all cause death and rehospitalization for heart failure in patients with acute myocardial infarction
Bin Xiong, Li-Min He, An Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Efficacy and Safety of Application of SGLT-2 Inhibitors in Patients Undergoing PCI after Acute Myocardial Infarction: A Meta Analysis
樱容 庞
Advances in Clinical Medicine (2024) Vol. 14, Iss. 07, pp. 791-801
Closed Access
Sodium‐Glucose Cotransporter‐2 Inhibitors After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Norman Lin, Jamie Sin Ying Ho, Aloysius Sheng‐Ting Leow, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
Efficacy and Safety of SGLT‐2 Inhibitors in Acute Myocardial Infarction: A Systematic Review and Meta‐Analysis
Hila Asham, Samad Ghaffari, Mohammadreza Taban Sadeghi, et al.
The Journal of Clinical Pharmacology (2024)
Open Access
Sodium-glucose cotransporter-2 inhibitors in acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
Matheus Meine, Paula Santo, Fabiana Dolovitsch de Oliveira, et al.
Heart Failure Reviews (2024)
Closed Access
Effects of new hypoglycemic drugs on patients with heart failure: a systematic review and network meta-analysis
Ruirui Song, Fang Liu, Xiaojing Shi, et al.
Postgraduate Medical Journal (2024)
Closed Access
A systematic review and meta-analysis assessing the safety and efficacy of sodium-glucose co-transporter 2 inhibitor use in hospitalized patients
Feng Gao, Aleena S. Ali, Rinaldo Bellomo, et al.
(2024)
Open Access
Effects of sodium‐glucose cotransporter‐2 inhibitors in myocardial infarction patients: A systematic review and meta‐analysis
Qiufeng Jia, Ankai Zuo, Hui Song, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access
The Use of Sodium-Glucose Cotransporter-2 Inhibitors in Coronary Revascularization: Where Are We Now? A Systematic Review
Ryaan EL‐Andari, Nicholas M. Fialka, Jimmy J.H. Kang, et al.
American Journal of Cardiovascular Drugs (2023)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top